Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

974 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Age-Stratified Analysis of First-Line Chemoimmunotherapy for Extensive-Stage Small Cell Lung Cancer: Real-World Evidence from a Multicenter Retrospective Study.
Takeda T, Yamada T, Kunimatsu Y, Tanimura K, Morimoto K, Shiotsu S, Chihara Y, Okada A, Horiuchi S, Hibino M, Uryu K, Honda R, Yamanaka Y, Yoshioka H, Kurata T, Takayama K. Takeda T, et al. Among authors: yamanaka y. Cancers (Basel). 2023 Feb 28;15(5):1543. doi: 10.3390/cancers15051543. Cancers (Basel). 2023. PMID: 36900334 Free PMC article.
First-Line Chemoimmunotherapy versus Sequential Platinum-Based Chemotherapy Followed by Immunotherapy in Patients with Non-Small Cell Lung Cancer with ≤49% Programmed Death-Ligand 1 Expression: A Real-World Multicenter Retrospective Study.
Tanimura K, Takeda T, Kataoka N, Yoshimura A, Nakanishi K, Yamanaka Y, Yoshioka H, Honda R, Uryu K, Fukui M, Chihara Y, Takei S, Kawachi H, Yamada T, Tamiya N, Okura N, Yamada T, Murai J, Shiotsu S, Kurata T, Takayama K. Tanimura K, et al. Among authors: yamanaka y. Cancers (Basel). 2023 Oct 14;15(20):4988. doi: 10.3390/cancers15204988. Cancers (Basel). 2023. PMID: 37894357 Free PMC article.
Impact of the response to platinum-based chemotherapy on the second-line immune checkpoint inhibitor monotherapy in non-small cell lung cancer with PD-L1 expression ≤49%: a multicenter retrospective study.
Yoshimura A, Takeda T, Kataoka N, Tanimura K, Fukui M, Chihara Y, Takei S, Kawachi H, Nakanishi K, Yamanaka Y, Tamiya N, Honda R, Okura N, Yamada T, Uryu K, Murai J, Shiotsu S, Yoshioka H, Yamada T, Kurata T, Takayama K. Yoshimura A, et al. Among authors: yamanaka y. Front Oncol. 2024 Jan 26;14:1303543. doi: 10.3389/fonc.2024.1303543. eCollection 2024. Front Oncol. 2024. PMID: 38344209 Free PMC article.
Detection of a Prethrombotic State in Patients with Hepatocellular Carcinoma, Using a Clot Waveform Analysis.
Fukui S, Wada H, Ikeda K, Kobayashi M, Shimada Y, Nakazawa Y, Mizutani H, Ichikawa Y, Nishiura Y, Moritani I, Yamanaka Y, Inoue H, Shimaoka M, Shimpo H, Shiraki K. Fukui S, et al. Among authors: yamanaka y. Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241246002. doi: 10.1177/10760296241246002. Clin Appl Thromb Hemost. 2024. PMID: 38591954 Free PMC article.
Ultrasonic humidifier lung with a reversed halo sign: A case report.
Hasegawa T, Ryu K, Fukuda T, Mizobuchi Y, Yoshimatsu L, Sato R, Takatsuka M, Shinfuku K, Yamada M, Yamanaka Y, Hosaka Y, Seki A, Takasaka N, Ishikawa T, Araya J. Hasegawa T, et al. Among authors: yamanaka y. Radiol Case Rep. 2024 Apr 4;19(6):2520-2524. doi: 10.1016/j.radcr.2024.03.032. eCollection 2024 Jun. Radiol Case Rep. 2024. PMID: 38585406 Free PMC article.
The impact of chronic obstructive pulmonary disease on bone strength.
Tsukamoto M, Nabeshima T, Wang KY, Mano Y, Arakawa D, Okada Y, Yamanaka Y, Okimoto N, Sakai A. Tsukamoto M, et al. Among authors: yamanaka y. J Bone Miner Metab. 2024 Feb 7. doi: 10.1007/s00774-024-01496-5. Online ahead of print. J Bone Miner Metab. 2024. PMID: 38326630 Review.
Differentiation between Parkinson's Disease and the Parkinsonian Subtype of Multiple System Atrophy Using the Magnetic Resonance T1w/T2w Ratio in the Middle Cerebellar Peduncle.
Wang J, Sugiyama A, Yokota H, Hirano S, Yamamoto T, Yamanaka Y, Araki N, Ito S, Paul F, Kuwabara S. Wang J, et al. Among authors: yamanaka y. Diagnostics (Basel). 2024 Jan 17;14(2):201. doi: 10.3390/diagnostics14020201. Diagnostics (Basel). 2024. PMID: 38248077 Free PMC article.
Discovery of ASP6918, a KRAS G12C inhibitor: Synthesis and structure-activity relationships of 1-{2,7-diazaspiro[3.5]non-2-yl}prop-2-en-1-one derivatives as covalent inhibitors with good potency and oral activity for the treatment of solid tumors.
Imaizumi T, Shimada I, Satake Y, Yamaki S, Koike T, Nigawara T, Kaneko O, Amano Y, Mori K, Yamanaka Y, Nakayama A, Nishizono Y, Shimazaki M, Nagashima T, Kuramoto K. Imaizumi T, et al. Among authors: yamanaka y. Bioorg Med Chem. 2024 Jan 15;98:117581. doi: 10.1016/j.bmc.2023.117581. Epub 2023 Dec 27. Bioorg Med Chem. 2024. PMID: 38176113
974 results